Browse studies
Find your next paid study
27 recruiting studies matching your filters
Phase 3
A Multicenter, Open-Label, Extension Study Evaluating the Safety and Efficacy of Bomedemstat for the Treatment of Participants Enrolled in a Prior Bomedemstat Clinical Study
The primary purpose of the study is to transition participants into an extension study to collect long-term safety and efficacy data. The study will include pa…
Thrombocythemia, EssentialPrimary MyelofibrosisMyelofibrosis+3 more
Estimated
~$10 – $8,750
Merck Sharp & Dohme LLCNCT06351631
Phase 3
Randomized, Open-label, Multicenter Phase 3 Study to Assess the Efficacy and Safety of GIVinostat Versus Hydroxyurea IN JAK2V617F-positive High-risk Polycythemia Vera Patients: the GIV-IN PV TRIAL
The goal of this clinical trial is to compare the efficacy and safety of givinostat to hydroxyurea in Jak2V617F-positive high risk polycythemia vera patients.
Polycythemia Vera
Estimated
~$10 – $7,500
ItalfarmacoNCT06093672
Phase 2
MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
Low-dose MTX is a widely used, inexpensive, and safe therapy used for decades and is well tolerated by patients with rheumatologic diseases. Recently, it was i…
Polycythemia Vera (PV)Essential Thrombocythemia (ET)Myelofibrosis (MF)
Estimated
~$10 – $6,250
Icahn School of Medicine at Mount SinaiNCT06541249